NIAID Funding News - March 15, 2017

Feature Articles

Opportunities and Resources

In The News

Advice Corner

New Funding Opportunities


Feature Articles

Where Are They Now? NIAID’s Find a Funding Opportunity Webpages

Our Research Funding website content migrated to a new NIAID website structure in September 2016, as discussed in Where Are They Now? NIAID's Top Extramural Webpages in our March 1, 2017 issue.

In Part II of our series about popular relocated content, we cover the Find a Funding Opportunity section, which includes the following pages:

Funding Opportunities and Policy News
Solicited and Unsolicited Applications, Plus Guidance on Types of Awards
Matching Your Application to NIAID Research Priorities
See What’s Being Funded and Find Collaborators
  • See Funded Projects Using RePORTER. Use this database of NIH-funded projects, publications, and patents to identify well-supported and underrepresented research areas and find potential collaborators for your next project.  
Understand Our Timelines When Applying For and Managing Your Grant

Stay tuned for the next article in this series, which will report on the Apply for a Grant section of NIAID’s redesigned website.


Opportunities and Resources 

Need Specimens for HIV or TB Research? Check Out These Repositories

We have a suggestion for you if you want access to specimens for HIV or tuberculosis (TB) research but don’t know where to look. Check out two repositories below that may have what you need. 

For Research on HIV and HIV-Related Co-Infections and Co-Morbidities

The Specimen Repository stores more than three million specimen types from the AIDS Clinical Trials Group (ACTG) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

These include blood, serum, plasma, sputum, peripheral blood mononuclear cells, tissue, and other body fluids such as cerebrospinal fluid, semen, and endocervical and cervicovaginal lavage fluid.
 
To explore what is available, go to Search the Repositories. After choosing and submitting specimen options, you’ll get a results report with the number of specimens and unique participants available, information about the studies for which they were collected, and what research was published for those studies.

If you need to search for options that aren’t listed, you may request a custom search by going to Contact Us.

You can then print, download or link to the report, which can help you write a research proposal to either ACTG or IMPAACT. For more on this, read Submit a Proposal.

For Research on TB

Composed of the Global Alliance for TB Drug Development, the TB Trials Consortium, and the AIDS Clinical Trials Group, the Consortium for TB Biomarkers (CTB2) created the CTB2 Biorepository.

This collaborative biobank’s available specimens include sputum, urine, plasma, RNA from whole blood (PAXgene), and QuantiFERON from whole blood. Learn more at Types of Samples Available.

Ultimately, the CTB2 repository will house biospecimens from 1,000 adult patients in long-term storage for use by the TB research community.
 
To find out more about requesting specimens, go to Applying for Samples. The current application cycle ends May 5, 2017. Before submitting, email tbbiorepository@tballiance.org or call 212-227-7540 to set up a time to discuss your application.

Additional Questions

For both the HIV and TB repositories, use the contact information listed above to submit inquiries, such as questions about what clinical information is provided with samples.


In The News 

Consolidating the Continuous Submission Policy

NIH recently consolidated seven old Guide notices related to continuous submission into a single clarified March 2, 2017 Guide notice. The policy itself remains the same.

To recap, NIH's continuous submission policy allows appointed members of review and advisory groups as well as reviewers who served six times in the past 18 months to send R01, exploratory or developmental grant (R21), and planning grant (R34) applications at any time for an opportunity that uses standard due dates. This includes the standard AIDS due dates.

The policy means you can submit after the standard due date and your application will be reviewed with other applications from that same review cycle. Continuous submission shortens the time from application submission to review by about two months.

See the table below for how advisory Council rounds relate to your application timing.

 

Schedule for Assignment to Advisory Council Rounds Under Continuous Submission Option
  Standard Due Dates Continuous Submission Period
Council Round R01 R21, R34 Type Submission Dates

May

October 5,
November 5
October 16,
November 16
Non-AIDS August 17 to December 16
January 7 January 7 AIDS October 8 to February 7

October

February 5,
March 5
February 16,
March 16
Non-AIDS December 17 to April 16
May 7 May 7 AIDS February 8 to June 7

January

June 5,
July 5
June 16,
July 16
Non-AIDS April 17 to August 16
September 7 September 7 AIDS June 8 to October 7

As before, you can check whether you are eligible for continuous submission in the Reviewer Information section of your eRA Commons Personal Profile. See How To Check Your Continuous Submission Eligibility. NIH also publishes a list at Applicants Eligible for Continuous Submission.

If you don't qualify, consider Serving on a Peer Review Committee. In addition to the timing benefit described above, volunteering as a peer reviewer is a rewarding and enlightening experience. You can learn firsthand what impresses reviewers as well as get exposure, experience, connections, and a broader view of your field.


News Briefs

General Registration for NIH Regional Seminar in New Orleans Is Open Now

Join over 60 NIH scientific review officers, program officers, and grants management specialists at the upcoming Regional Seminar in New Orleans, Louisiana, from May 3 to 5, 2017, to get the inside scoop on applying for NIH grants, managing NIH awards, and navigating NIH programs to advance your career.

In addition to the regional seminar in New Orleans, NIH will host a regional seminar in Baltimore, Maryland, on October 25 to 27, 2017.

Go to 2017 NIH Regional Seminar to learn more.


Advice Corner 

Finding the Sweet Spot for Your Diversity Supplement Application 

The Research Supplements To Promote Diversity in Health-Related Research funding opportunity announcement (FOA) supports research experiences to enhance participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral and social sciences.

The proposed research experience must be an integral part of the approved, ongoing research of the parent award, and it must have the potential to contribute significantly to the research career development of the candidate.

As stated in the Notice of NIH’s Interest in Diversity, programs such as these “foster diversity by addressing underrepresentation in the scientific research workforce, which is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital.”

Candidate Eligibility

Investigators who mentor underrepresented individuals can apply for diversity supplements to support eligible high school students, undergraduate students, baccalaureate, predoctoral and health professional students, postdoctoral candidates, or even investigators developing independent research careers.

The application should focus strongly on the specific purpose of the diversity supplement and candidate’s research project.

In some instances, we’ve seen diversity supplements serve as a platform for a candidate to gain the research experience necessary to then earn an independent grant award (e.g., fellowship, career development award, or small research grant).

Research Scope

As part of your diversity supplement application, you must include a research plan to describe the candidate’s proposed research, career development, and mentoring. Listed below are further details:

  • Proposed Research Project
    • Describe how the mentored research experiences will expand and foster the research capabilities of the candidate.
    • Describe how the research experience relates to the research goals and objectives of the parent grant and clearly indicate what aspect of the research will be performed independently by the candidate.
    • Provide evidence that the research is appropriate for the career stage of the candidate.
    • Explain how the experience will significantly enhance the candidate’s research potential while furthering the candidate’s ability to pursue a research career.
  • Career Development/Mentoring
    • Include objectives and associated timelines for helping the candidate make the transition to the next stage of his or her research career.
    • Detail interactions between you and the candidate as well as other individuals in the laboratory (e.g., seminars, lab meetings, how progress will be monitored).
    • Provide a projected timeline delineating specific research milestones and other activities (e.g., anticipated publications, grantsmanship workshops, timeframe for grant submissions) that will be made to secure independent research funding for the candidate.
    • Describe how you as the mentor will assist the candidate in achieving the objectives and goals described by the candidate in his or her statement.

Overall, your research plan should focus on enhancing the candidate’s research capability and providing opportunities for growth and development.

Keep in mind that while the proposed research experience must be within the scope of the parent award, it cannot be research already paid for by the parent award. We want you to plan work intentionally designed to build the candidate’s research experience.

In this way, although you are staying within the parameters of the parent award, your application’s Specific Aims should center on creating opportunities for the candidate to gain new research experience and enhance his or her competitiveness for future independent awards.

Learn more at Research Supplements To Promote Diversity in Health-Related Research.


Reader Questions 

You can ask us a question at deaweb@niaid.nih.gov. After responding, we may ask your permission to include your question in the newsletter. 

“How do I know if the Center for Scientific Review or an institute will review my application?”—anonymous reader

Check Section VII. Agency Contacts of the funding opportunity announcement under Peer Review Contact(s). The listed contact’s organization will indicate the locus of review.

NIAID reviews applications for program project grants, cooperative agreements, career awards, institutional training grants, conference grants, investigator-initiated clinical trial planning and implementation awards, and applications responding to requests for applications (RFAs).

NIH’s Center for Scientific Review reviews investigator-initiated grant applications for all other award types.

For more on this topic, read First-Level Peer Review.

“If I relocate to another country, can I take my NIH funding with me?”—anonymous reader

Possibly, though the approval process is complex. First, contact your institution, which must be willing to relinquish your grant to a new institution. This move can be complicated, and NIAID is not involved with that decision or any negotiations related to it.

If your institution approves the move, submit a prior approval request to your grants management specialist. A request to change your institution to another foreign country requires approval by NIAID's advisory Council. Follow the instructions here:


New Funding Opportunities 

See other announcements at Opportunities & Announcements.​​

Content last reviewed on March 15, 2017